iSD Immunotech
PrivateLast Round
Seed
Oct 11, 2021
Company Overview
iSD Immunotech is a biotechnology company developing peptide therapeutics to treat severe autoimmune diseases, specifically systemic lupus erythematosus (SLE) by targeting the STING pathway.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
iSD Immunotech Comparables
Compare iSD Immunotech with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| ImmuneSensor Therapeutics | 76% | |
| Novartis | 73% | |
| Astellas Pharma Inc. | 72% | |
iSD Immunotech Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Oct 11, 2021 | ||||
| Seed | Nov 23, 2020 |
iSD Immunotech Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Eir Ventures | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 11, 2021
Raised Seed round with Eir Ventures and novoholdings.
- Nov 23, 2020
Completed a Seed funding round with Novo Holdings.
iSD Immunotech Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about iSD Immunotech's valuation, stock price, and market status.